1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 12 Hits
  • 検索条件 : 絞込み (MeSH = Cholangiocarcinoma* / drug therapy)
生物種 リソース名 タイトル
ヒト・動物細胞 SSP-25(RCB1293) , HuCCT1(RCB1960) Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma.
ヒト・動物細胞 SSP-25(RCB1293) , HuCCT1(RCB1960) Heteronemin suppresses EGF‑induced proliferation through the PI3K/PD‑L1 signaling pathways in cholangiocarcinoma.
ヒト・動物細胞 TFK-1(RCB2537) Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866.
ヒト・動物細胞 RBE(RCB1292) , SSP-25(RCB1293) CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon.
ヒト・動物細胞 HuCCT1(RCB1960) , RBE(RCB1292) , SSP-25(RCB1293) Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression.
ヒト・動物細胞 HuCCT1(RCB1960) Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.
ヒト・動物細胞 TFK-1(RCB2537) SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting BIN1, MCL-1 and BCL2 Splicing Errors and Enabling Apoptosis of Cholangiocarcinoma Cells.
ヒト・動物細胞 RBE(RCB1292) , HuCCT1(RCB1960) SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
ヒト・動物細胞 RBE(RCB1292) EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
ヒト・動物細胞 HuCCT1(RCB1960) Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development.
ヒト・動物細胞 HuCCT1(RCB1960) , RBE(RCB1292) , SSP25(RCB1293) Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.